{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=112", "query": { "intervention": "CTRL", "page": 112 }, "page_size": 10 }, "pagination": { "page": 112, "page_size": 10, "total_count": 26682, "total_pages": 2669, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=113&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=111&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-13T01:45:37.755Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03737240", "title": "IDegLira HIGH Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "IDegLira", "type": "DRUG" }, { "name": "Insulin Degludec (U-100)", "type": "DRUG" }, { "name": "Insulin Aspart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 145, "start_date": "2019-01-15", "completion_date": "2022-07-08", "has_results": true, "last_update_posted_date": "2023-09-08", "last_synced_at": "2026-11-13T01:45:37.755Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03737240" }, { "nct_id": "NCT01998789", "title": "Everolimus Post Orthotopic Liver Transplant", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Orthotopic Liver Transplant" ], "interventions": [ { "name": "Everolimus", "type": "DRUG" }, { "name": "Standard Tacrolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tomoaki Kato", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2013-10", "completion_date": "2019-02", "has_results": false, "last_update_posted_date": "2017-08-10", "last_synced_at": "2026-11-13T01:45:37.755Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01998789" }, { "nct_id": "NCT04402489", "title": "Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "EPP", "XLP" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "MT-7117 Low Dose", "type": "DRUG" }, { "name": "MT-7117 High Dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tanabe Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 184, "start_date": "2020-06-01", "completion_date": "2022-07-26", "has_results": true, "last_update_posted_date": "2025-12-30", "last_synced_at": "2026-11-13T01:45:37.755Z", "location_count": 10, "location_summary": "Huntington Beach, California • Miami, Florida • Brighton, Massachusetts + 7 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Brighton", "state": "Massachusetts" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04402489" }, { "nct_id": "NCT05239468", "title": "Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Biliary Cholangitis" ], "interventions": [ { "name": "Bezafibrate 100 mg", "type": "DRUG" }, { "name": "Bezafibrate 200 mg", "type": "DRUG" }, { "name": "Obeticholic Acid 5 mg", "type": "DRUG" }, { "name": "Obeticholic Acid placebo", "type": "DRUG" }, { "name": "Bezafibrate Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Intercept Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2022-03-21", "completion_date": "2025-09-01", "has_results": true, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-11-13T01:45:37.755Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Coronado, California • Mission Hills, California + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Coronado", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05239468" }, { "nct_id": "NCT07344558", "title": "A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Idiopathic Pulmonary Fibrosis (IPF)" ], "interventions": [ { "name": "MNKD-201(Nintedanib DPI)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mannkind Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 27, "start_date": "2025-12-22", "completion_date": "2026-06-17", "has_results": false, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-11-13T01:45:37.755Z", "location_count": 9, "location_summary": "Fresno, California • Palm Springs, California • Doral, Florida + 5 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Palm Springs", "state": "California" }, { "city": "Doral", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07344558" }, { "nct_id": "NCT00810758", "title": "Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis C Virus" ], "interventions": [ { "name": "PF-04878691 3mg", "type": "DRUG" }, { "name": "PF-04878691 6mg", "type": "DRUG" }, { "name": "PF-04878691 9mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 24, "start_date": "2009-01", "completion_date": "2009-11", "has_results": false, "last_update_posted_date": "2009-12-01", "last_synced_at": "2026-11-13T01:45:37.755Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00810758" }, { "nct_id": "NCT01954238", "title": "A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "GCC-4401C", "type": "DRUG" }, { "name": "Rivaroxaban", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Green Cross Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 46, "start_date": "2013-08", "completion_date": "2014-05", "has_results": false, "last_update_posted_date": "2014-12-23", "last_synced_at": "2026-11-13T01:45:37.755Z", "location_count": 1, "location_summary": "Early Phase Clinical Unit _Los Angeles, California", "locations": [ { "city": "Early Phase Clinical Unit _Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01954238" }, { "nct_id": "NCT02647658", "title": "Targeted Interventions to Prevent Chronic Low Back Pain in High Risk Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Low Back Pain" ], "interventions": [ { "name": "Guideline Based Care plus Psychologically Informed Physical Therapy", "type": "BEHAVIORAL" }, { "name": "Guideline Based Care (GBC)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2300, "start_date": "2016-03", "completion_date": "2019-06-30", "has_results": true, "last_update_posted_date": "2020-02-10", "last_synced_at": "2026-11-13T01:45:37.755Z", "location_count": 5, "location_summary": "Baltimore, Maryland • Boston, Massachusetts • Pittsburgh, Pennsylvania + 2 more", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02647658" }, { "nct_id": "NCT01054443", "title": "A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Immune Thrombocytopenia (ITP)" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Lusutrombopag", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shionogi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2010-03-18", "completion_date": "2010-11-24", "has_results": true, "last_update_posted_date": "2021-03-18", "last_synced_at": "2026-11-13T01:45:37.755Z", "location_count": 19, "location_summary": "Anaheim, California • Los Angeles, California • Washington D.C., District of Columbia + 15 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Boynton Beach", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01054443" }, { "nct_id": "NCT01749215", "title": "A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Alcohol Dependence", "Posttraumatic Stress Disorder (PTSD)" ], "interventions": [ { "name": "Topiramate", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "Medical Management", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 151, "start_date": "2013-02", "completion_date": "2019-07", "has_results": true, "last_update_posted_date": "2021-06-21", "last_synced_at": "2026-11-13T01:45:37.755Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01749215" } ] }